Safety and efficacy of Avatec® 150G (lasalocid A sodium) for chickens for fattening and chickens reared for laying, and modification of the terms of authorisation for chickens for fattening, chickens reared for laying, turkeys for fattening, minor avian species (pheasants, guinea fowl, quails and partridges) except laying birds
- PMID: 32625606
- PMCID: PMC7010116
- DOI: 10.2903/j.efsa.2017.4857
Safety and efficacy of Avatec® 150G (lasalocid A sodium) for chickens for fattening and chickens reared for laying, and modification of the terms of authorisation for chickens for fattening, chickens reared for laying, turkeys for fattening, minor avian species (pheasants, guinea fowl, quails and partridges) except laying birds
Abstract
Avatec® 150G is an anticoccidial feed additive containing 15% of the active ingredient lasalocid A sodium, an ionophore anticoccidial. The tolerance study indicated that oral administration of lasalocid A sodium via feed at doses at and above the targeted lasalocid dose of 125 mg/kg was not tolerated in chickens for fattening. Consequently, no safe dose can be established by the tolerance study submitted. Concurrent administration of lasalocid with tiamulin and certain other medicinal substances should be avoided. Lasalocid sodium has a selective antimicrobial activity against Gram-positive bacterial species while many Enterobacteriaceae are naturally resistant. Induction of resistance and/or cross-resistance was not observed in experimental conditions. Lasalocid A sodium is not genotoxic and not carcinogenic. The newly conducted cardiovascular study in dogs indicated an acute no-observed-adverse-effect level (NOAEL) of 1 mg/kg body weight (bw) per day. Since this NOAEL is above the lowest NOAEL of 0.5 mg/kg bw per day previously identified in a 2-year toxicity study in rats and a developmental study in rabbits, it is concluded that this NOAEL (0.5 mg/kg bw per day) is an appropriate base for establishing an Acceptable Daily Intake of 0.005 mg lasalocid sodium/kg bw. The use of lasalocid A sodium from Avatec® 150G at the highest proposed level of 125 mg/kg complete feed is safe for the consumer. For compliance with the maximum residue limits (MRLs), a withdrawal period of 3 days is necessary. No risk for the user is expected from the use of Avatec® 150G. The use of lasalocid A sodium from Avatec® 150G in feed for chickens for fattening and chickens reared for laying up to the highest proposed dose does not pose a risk for the environment. Insufficient evidence of the anticoccidial efficacy of lasalocid A sodium was provided in chickens for fattening/reared for laying.
Keywords: Avatec; Coccidiostat; efficacy; lasalocid A sodium; poultry; safety.
© 2017 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.
Figures
References
-
- Anderson RC, Harvey RB, Wickersham TA, MacDonald JC and Ponce CH, 2014. Effect of distillers feedstuffs and lasalocid on Campylobacter carriage in feedlot cattle. Journal of Food Protection, 77, 1968–1975. - PubMed
-
- Dimenna GP, Lyon FS, Thompson FM, Creegan JA and Wrigt GJ, 1988. Effect of antibiotic combination, dosing period, dose vehicle and assay method on salinomycin residue levels and their ionophoricity in chicken tissues. Journal of Agriculture and Food Chemistry, 37, 668–676.
-
- Donoho AL, 1984. Presented at a symposium on “Monensin in Cattle” held August 10, 1982 at the Joint Annu. Meet. Can‐Amer. Soc. Of Anima. Sci. Univ. of Guelph, Guelph, Canada.
-
- Edrington TS, Looper ML, Duke SE, Callaway TR and Genovese KJ, 2006. Effect of ionophore supplementation on the incidence of Escherichia coli O157:H7 and Salmonella and antimicrobial susceptibility of fecal coliforms stocker cattle. Foodborne Pathog Diseases, 3, 284–291. - PubMed
-
- EFSA (European Food Safety Authority), 2004a. Opinion of the Scientific Panel on additives and products or substances used in animal feed on the re‐evaluation of coccidiostat Avatec in accordance with article 9G of Council Directive 70/524/EEC. EFSA Journal 2004;2(5):53, 44 pp. 10.2903/j.efsa.2004.53 - DOI
LinkOut - more resources
Full Text Sources